Copyright © 2013 Ralph Yachoui et al.is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. e Stevens-Johnson syndrome (SJS) classically involves a targetoid skin rash and the association of the oral mucosa, genitals, and conjunctivae. Recently, there have been several documentations of an incomplete presentation of this syndrome, without the typical rash, usually associated with the mycoplasma pneumoniae infection. Our case illustrates that this important clinical diagnosis should not be missed due to its atypical presentation. 1
Stevens-Johnson syndrome is a severe mucocutaneous disease following drugs or infections. We present...
Mycoplasma pneumoniae-associated mucositis (MPAM), previously labelled as atypical Stevens-Johnson s...
Mycoplasma pneumoniae-induced rash and mucositis (MIRM) is a recently described clinical entity and ...
The Stevens-Johnson syndrome (SJS) classically involves a targetoid skin rash and the association of...
Copyright © 2012 Samad Rasul et al. This is an open access article distributed under the Creative Co...
Introduction: Mycoplasma pneumoniae is a worldwide occurring common bacterial agent for community-ac...
Stevens-Johnson syndrome (SJS) is a mucocutaneous reaction typically brought on by medications or in...
To describe a case of Stevens-Johnson syndrome associated with Mycoplasma infection and demonstrate ...
Mycoplasmapneumoniae is a common cause of respiratory infections. Although most cases are mild, some...
Mycoplasma pneumoniae (MP) frequently causes bacterial upper respiratory tract infections, especiall...
BACKGROUND Mycoplasma pneumoniae may induce mucosal inflammation, referred to as M. pneumoniae-asso...
This review aims to examine the current concepts of mycoplasmosis, its prevalence, different etiolog...
Mycoplasma pneumoniae (MP) frequently causes bacterial upper respiratory tract infections, especiall...
Background: Stevens-Johnson syndrome (SJS) associated with Mycoplasma pneumoniae (M. pneumoniae) inf...
Fuchs’ syndrome (Stevens-Johnson syndrome without skin involvement) is a sporadically diagnosed dise...
Stevens-Johnson syndrome is a severe mucocutaneous disease following drugs or infections. We present...
Mycoplasma pneumoniae-associated mucositis (MPAM), previously labelled as atypical Stevens-Johnson s...
Mycoplasma pneumoniae-induced rash and mucositis (MIRM) is a recently described clinical entity and ...
The Stevens-Johnson syndrome (SJS) classically involves a targetoid skin rash and the association of...
Copyright © 2012 Samad Rasul et al. This is an open access article distributed under the Creative Co...
Introduction: Mycoplasma pneumoniae is a worldwide occurring common bacterial agent for community-ac...
Stevens-Johnson syndrome (SJS) is a mucocutaneous reaction typically brought on by medications or in...
To describe a case of Stevens-Johnson syndrome associated with Mycoplasma infection and demonstrate ...
Mycoplasmapneumoniae is a common cause of respiratory infections. Although most cases are mild, some...
Mycoplasma pneumoniae (MP) frequently causes bacterial upper respiratory tract infections, especiall...
BACKGROUND Mycoplasma pneumoniae may induce mucosal inflammation, referred to as M. pneumoniae-asso...
This review aims to examine the current concepts of mycoplasmosis, its prevalence, different etiolog...
Mycoplasma pneumoniae (MP) frequently causes bacterial upper respiratory tract infections, especiall...
Background: Stevens-Johnson syndrome (SJS) associated with Mycoplasma pneumoniae (M. pneumoniae) inf...
Fuchs’ syndrome (Stevens-Johnson syndrome without skin involvement) is a sporadically diagnosed dise...
Stevens-Johnson syndrome is a severe mucocutaneous disease following drugs or infections. We present...
Mycoplasma pneumoniae-associated mucositis (MPAM), previously labelled as atypical Stevens-Johnson s...
Mycoplasma pneumoniae-induced rash and mucositis (MIRM) is a recently described clinical entity and ...